← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Abeome Corporation
Athens, GA
$2,334,449
Total funding
6
Grants
Funding over time
peak $809.6K · FY2010–17$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,334,449 · 6
By mechanism
R44$1,482,472 · 1
R43$851,977 · 5
Investigators at Abeome Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Therapeutic Approach to Hypercholesterolemia Using Anti-PCSK9 Selected Immune Repertoires$809,592
R44 · FY2016 · HL
Novel Therapeutic Approach to Hypercholesterolemia Using Anti-PCSK9 Selected Immune Repertoires$672,880
R44 · FY2017 · HL
Semi-targeted Immuno-Therapeutic Approach for Treatment of Obesity$275,916
R43 · FY2013 · DK
Novel Therapeutic Approach to Hypercholesterolemia Using Next-Generation DNA Sequ$242,066
R43 · FY2014 · HL
Development of a transgenic mouse line engineered to permit selection and cloning$133,995
R43 · FY2010 · RR
Novel Caenorhabditis Elegans Reagents$100,000
R43 · FY2004 · GM
Novel Markers on Human Embryonic Stem Cells$100,000
R43 · FY2004 · GM